Calamity BLU f#ck up againLooks like they f#cked up on dosage or recruitment/eligibility, efficacy potential, something went wrong. It was potentially best in class for non taste loss not for number of coughs. So why wasn't that taken into account and allowed for in the statistical analysis???? Bottom line you do not go from potentially best in class to flunking a phase 2 so dramatically for no good reason.